Key result
A 71-year-old immunocompetent man with primary cardiac lymphoma achieved clinical remission for 2 years.
Case Report (n=1)
This case report highlights that primary cardiac lymphoma, though rare, can be successfully managed with anthracycline-based chemotherapy leading to sustained clinical remission.
May support anthracycline chemotherapy in rare primary cardiac lymphoma; hypothesis-generating and requires prospective validation.
Isolated cardiac lymphomas are very rare, especially in immunocompetent patients. As a consequence, little is known about the best therapeutic management and about patients' outcomes in these cases. Diffuse large B-cell lymphoma is the most frequent subtype; anthracycline-based chemotherapy has been the most successful treatment. We describe the case of a primary cardiac lymphoma in an immunocompetent 71-year-old man. As of December 2015, the patient had been in clinical remission for 2 years. The most relevant literature on primary cardiac lymphoma is reported and discussed.
No takes yet. Share an insight, caveat, or question.
Montanaro et al. (2015) conducted a case report in Primary cardiac lymphoma (n=1). Anthracycline-based chemotherapy was evaluated on Clinical remission. A 71-year-old immunocompetent man with primary cardiac lymphoma achieved clinical remission for 2 years.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: